GlassScriptPhysician profile
Sean Childs
NPI 1508250127
$9,337.69
in general payments reported to CMS, 2019-2025
9 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,277 · 2022: $2,054 · 2023: $1,884 · 2024: $2,821 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894 · Travel and Lodging: $2,880 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,894.14 |
| Travel and Lodging | $2,879.68 |
| Education | $232.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,419.80 | 2022-2025 | Persona, Arcos, Rosa |
| Prodigy Surgical Distribution, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $209.32 | 2021-2022 | |
| Medical Device Business Services, INC. | $169.09 | 2023 | Actis, Attune |
| Orthalign INC | $141.50 | 2024 | Orthalign Plus |
| Biocomposites INC | $115.33 | 2024 | |
| Solventum Corporation | $38.84 | 2025 | Prevena |
| Convatec INC. | $23.79 | 2023 | |
| Davol INC. | $20.02 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Childs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.